Aquarius Equity Partners is a Manchester, England based investment firm. They manage the funds of high net worth individuals and family offices, and focus on private equity and venture capital investments in the United Kingdom. The firm prefers investments in the life science, biotechnology, therapeutics and medical device sectors.
Aquarius Equity Partners manages two funds: The Aquarius Origin Fund LLP and the Aquarius IV Fund LLP.
Aquarius Equity Partners has made investments in Nanoco Group, Tissue Regenix, Auralis, hVIVO, C4X Discovery and Brabant pharma.
They have exited their investments in C4X Discovery, Tissue Regenix, hVIVO, Nanoco Group, Brabant pharma, Auralis.